Lemtrada® (Alemtuzumab) is a medication used to treat adults with relapsing forms of multiple sclerosis (MS).
Lemtrada® is manufactured by Sanofi.
Administration and Dosage:
Administration of LEMTRADA® is intravenously infused over 4 hours for a 2 or more treatment course. First course consists of 12mg/ day for 5 consecutive days followed by 12mg/day on 3 consecutive days 12 months after the first course.
Common Side Effects:
The more common side effects of LEMTRADA® include serious autoimmune problems, serious infusion reactions, certain cancers, and stroke and tears in your arteries that supply blood to your brain (carotid and vertebral arteries).
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
Lemtrada® is indicated to treat:
- Forms of Relapsing Multiple Sclerosis